An 80-year-old systemically stable female presented with sudden blurring of vision post the first dose of Covishield, a non-replicating viral vector vaccine. On examination, she was found to have bilateral serous choroidal effusions. A thorough systemic and ocular workup was performed to rule out other causes of choroidal effusion. The effusions resolved with tapering doses of oral and systemic steroids. To the best of our knowledge, at the time of submission, this is the first case of choroidal effusion being reported after the coronavirus disease 2019 (COVID-19) vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940547 | PMC |
| http://dx.doi.org/10.4103/ijo.IJO_946_22 | DOI Listing |
Publication Analysis
Top Keywords
choroidal effusion
12
bilateral choroidal
4
effusion vaccination
4
vaccination sars-cov-2
4
sars-cov-2 virus
4
virus 80-year-old
4
80-year-old systemically
4
systemically stable
4
stable female
4
female presented
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!